Abstract
The effects of the serotonin reuptake inhibitor fluoxetine (FL) and its complexes with glycyrrhizic acid (GA) in molar ratios of 1:1 (FLG-1) and 4:1 (FLG-4) on the behavior of adult rats were studied in an elevated cross maze, with measurement of brain monoamine and monamine metabolite levels. Agents were given via the intragastric route using a cannula at a dose of 25 mg/kg 1 h before testing. FL increased anxiety in the rats and decreased their movement activity; FLG-1 and FLG-4 had no effect on behavior. None of the agents affected brain serotonin content, though all decreased the levels of its metabolite 5-hydroxyindoleacetic acid in the hypothalamus, FLG-4 also decreasing this in the cortex. Noradrenaline levels in the hypothalamus were increased after FLG-1 and FLG-4. In the striatum, FL increased the levels of dopamine and its metabolite dihydroxyphenylacetic acid but had no effect on the level of transmitter catabolism. Unlike FL, FLG-1 activated dopamine metabolism in the striatum. Overall, use of FL complexed with GA significantly modified its behavioral effects, which appears to be associated with the effects of FL and its complexes on the function of the monoaminergic systems involved in controlling behavior.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Russian Patent No. 2180583, BIPM No. 8, 148 (2002).
K. S. Raevskii, T. D. Sotnikova, and R. R. Gainetdinov, “The brain dopaminergic system: receptor heterogeneity, functional role, and pharmacological regulation,” Usp. Fiziol. Nauk., 27, No. 4, 3–29 (1996).
P. Blier and C. De Montigny, “Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders,” Neuropsychopharmacology, 21, Suppl. 1, S91–S98 (1999).
S. Caccia, C. Fracasso, S. Garattini, G. Guiso, and S. Sarati, “Effects of short-and long-term administration of fluoxetine on the monoamine content of rat brain,” Neuropharmacology, 31, No. 4, 343–347 (1992).
J. A. Den Boer, “Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology, and treatment,” Comp. Psychiatry, 41, No. 6, 405–415 (2000).
B. Giros, M. Jaber, S. R. Jones, R. M. Wightman, and M. G. Caron, “Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter,” Nature, 379, No. 6566, 606–612 (1996).
A. Gobert, J. M. Rivet, L. Cistarelli, C. Melon, and M. J. Millan, “Alpha2-adrenergic receptor blockade markedly potentiates duloxetine-and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats,” J. Neurochem., 69, No. 6, 2616–2619 (1997).
A. Holmes, R. J. Yang, K. P. Lesch, J. N. Crawley, and D. L. Murray, “Mice lacking the serotonin transporter exhibit 5-HT(lA) receptor-mediated abnormalities in tests for anxiety-like behavior,” Neuropsychopharmacology, 28, No. 12, 2077–2088 (2003).
Z. A. Hughes and S. C. Stanford, “Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex,” Eur. J. Pharmacol., 317, No. 1, 83–90 (1996).
J. Ichikawa and H. Y. Meltzer, “Effect of antidepressants on striatal and accumbens extracellular dopamine levels,” Eur. J. Pharmacol., 281, No. 3, 255–261 (1995).
S. Koch, K. W. Perry, D. L. Nelson, R. G. Conway, P. G. Threlkeld, and F. P. Bymaster, “R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study,” Neuropsychopharmacology, 27, No. 6, 949–959 (2002).
M. Kurt, A. C. Arik, and S. Celik, “The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice,” J. Basic Clin. Physiol. Pharmacol., 11, No. 2, 173–180 (2000).
J. Mukherjee and Z. Y. Yang, “Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study,” Eur. J. Pharmacol., 337, No. 1, 111–114 (1997).
J. Mukherjee and Z. Y. Yang, “Monoamine oxidase A inhibition by fluoxetine: an in vitro and in vivo study,” Synapse, 31, No. 4, 285–289 (1999).
K. W. Perry and R. W. Fuller, “Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-S04 and microdialysis in conscious rats,” J. Neural. Transm., 104, No. 8–9, 953–966 (1997).
S. Prisco and E. Esposito, “Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area,” Brit. J. Pharmacol., 116, No. 2, 1923–1931 (1995).
M. T. Silva, C. R. Alves, and E. M. Santarem, “Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze,” Braz. J. Med. Biol. Res., 32, No. 3, 333–339 (1999).
R. C. Silva and M. L. Brandao, “Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis,” Pharmacol. Biochem. Behav., 65, No. 2, 209–216 (2000).
C. Spielewoy, C. Roubert, M. Hamon, M. Nosten-Bertrand, C. Betancur, and B. Giros, “Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice,” Behav. Pharmacol., 11, No. 3–4 279–290 (2000).
D. Spinks and G. Spinks, “Serotonin reuptake inhibition: an update on current research strategies,” Curr. Med. Chem., 9, No. 8, 799–810 (2002).
A. Zocchi, G. Varnier, R. Arban, C. Griffante, L. Zanetti, L. Bettelini, M. Marchi, P. A. Gerrard, and M. Corsi, “Effects of antidepressant drugs and GR 205171, a neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse,” Neurosci. Lett., 345, No. 2, 73–76 (2003).
Author information
Authors and Affiliations
Additional information
__________
Translated from Zhurnal Vysshei Nervnoi Deyatel’nosti imeni I. P. Pavlova, Vol. 55, No. 2, pp. 207–212, March–April, 2005.
Rights and permissions
About this article
Cite this article
Shishkina, G.T., Dygalo, N.N., Yudina, A.M. et al. The effects of fluoxetine and its complexes with glycerrhizic acid on behavior in rats and brain monoamine levels. Neurosci Behav Physiol 36, 329–333 (2006). https://doi.org/10.1007/s11055-006-0021-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11055-006-0021-0